Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 2 months ago
growth and success and continues to strategically position itself for sustained impact, as articulated in the School’s Strategic Plan (https://pharmacy.unc.edu/about/oe/strategic-plan/). Our Vision is to
-
students and provides hands-on experience in biomaterials-based vaccine delivery within a multidisciplinary academic research environment. More information about the McHugh Lab can be found here: https
-
Park Headquarters Where to apply Website https://www.rfgi.es/ConvocatoriasPropiasFIMABIS/es/Convocatorias/VerConvocatori… Requirements Research FieldMedical sciences » Health sciencesEducation LevelPhD
-
design and applying them to create new medicines, vaccines, nanomaterials, enzymes, and more. The Institute is supported by diversified sources of funding including grants from private foundations, federal
-
, spreadsheets, and web-based applications. ● Conduct background literature research on relevant topics including current methods, reagents, and ethics. ● Prepare media, enzymes, and solutions under sterile
-
The selected candidate will work on the NCN-funded project aimed at investigating the interactions between human peptidylarginine deiminase 4 (PAD4) and various types of nucleic acids. PAD4 is an enzyme whose
-
phenotypes and responses using quantitative and reproducible methods Preparation of media, enzymes, and solutions under sterile conditions Experience performing molecular and biochemical analyses, including
-
for Antibiotic, Enzyme, Probiotic and Starter Cultures Technology of the Department of Biochemical Engineering, to work on the project: "Specific bioactive metabolites of postbiotics and probiotics produced using
-
focus heavily on worm and mouse model systems. Experimental responsibilities will include, but are not limited to, the following: Design and perform PCR assays, restriction enzyme digests, and DNA
-
the human genome and transcriptome using nucleic acid-modifying enzymes, as well as developing peptide-based therapeutics. We discover, characterize, and engineer CRISPR-derived gene-editing agents and other